autism

Marketing

GW plots path to new drug approvals as Epidiolex coasts

GW announced a phase 3 trial to treat spasticity in MS on the same day it posted 3Q results that beat predictions, led by epilepsy drug Epidiolex.
Beth Snyder Bulik Nov 5, 2020 11:14am

GW Pharma looks to dispel cannabis stigma with Epidiolex launch

Oct 5, 2018 11:24pm

Twitter is rife with antivaccine sentiment: study

Oct 10, 2017 5:28pm

Trump's FDA pick: Vaccine, autism claims 'debunked'

Mar 13, 2017 12:46pm

Journal pulls latest flawed study linking vaccines to autism

Dec 6, 2016 4:04pm